 |
Articles: General Pharma |
Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09
Dendreon Appoints Hans Bishop as Chief Operating Officer
Dendreon Coproration, 12/11/09
Free full text
New study results presented at 2009 san antonio breast cancer symposium show importance of protecting your bones
Amgen, 12/11/09
Free full text
Phase III CONFIRM study shows FASLODEX (fulvestrant) Injection 500 mg may delay time of disease progression over 250-mg dose in postmenopausal women with hormone receptor-positive advanced breast cancer
AstraZeneca, 12/11/09
Free full text
Salix Pharmaceuticals Reports Concurrence with FDA on Content and Format of the Pending Rifaximin NDA in the Treatment of Non-Constipation Irritable Bowel Syndrome
Salix Pharmaceuticals, 12/11/09
Free full text
Sanofi-aventis and U.S Biotechnology company Alopexx enter into a collaboration agreement for a novel human monoclonal antibody targeting infectious diseases
Sanofi-aventis, 12/11/09
Free full text
RSNA Exhibitors Introduce Products
HealthDataManagement, 12/11/09 Hospira Buys Infection Control Vendor
HealthDataManagement, 12/11/09 Data Presented at San Antonio Breast Cancer Symposium Demonstrate Treatment with Denosumab is Superior to the Standard of Care
Amgen, 12/11/09
Free full text
Pre-Budget Report response - GSK comments on patent box
GlaxoSmithKline, 12/11/09
Free full text
KLAS Ranks PACS Products
HealthDataManagement, 12/11/09 Vendor Exec to Feds: Change Course
HealthDataManagement, 12/11/09 A holiday message from AHA President and CEO Rich Umbdenstock
American Hospital Association News, 12/11/09
Free full text
A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva, OSI-774) in patients with advanced solid tumors of epithelial origin
Cancer Chemotherapy and Pharmacology, 12/11/09 
Prior Articles
Roche Introduces New Automated Clinical Laboratory System for CE-Marked Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae
Roche, 12/10/09
Free full text
Important progress in treatment of early and late stage breast cancer with Herceptin, Avastin and T-DM1
Roche, 12/10/09
Free full text
Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America
Sanofi-aventis, 12/10/09
Free full text
Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging
Repligen, 12/10/09
Free full text
Sanofi-aventis establishes strategic research alliance with California Institute of Technology
Sanofi-aventis, 12/10/09
Free full text
Mediware Makes Two Buys
HealthDataManagement, 12/10/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
250 Available Pages
|
|
